Cargando…

MicroRNA-204 plays a role as a tumor suppressor in Newcastle disease virus-induced oncolysis in lung cancer A549 cells

Tumor development and progression are closely associated with various microRNAs (miRNAs/miRs). We have previously shown that Newcastle disease virus (NDV) strain 7793 induces oncolysis in lung cancer. However, how NDV exerts its oncolytic effect on lung cancer remains to be investigated. The present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Ying, Tian, Wen-Yu, Huang, Juan-Juan, Gao, Ling-Xi, Fan, Xiao-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100940/ https://www.ncbi.nlm.nih.gov/pubmed/33968198 http://dx.doi.org/10.3892/ol.2021.12743

Ejemplares similares

MicroRNA‐204‐5p: A pivotal tumor suppressor
por: Yang, Fan, et al.
Publicado: (2022)

Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
por: Jiang, Ke, et al.
Publicado: (2014)

Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
por: Jamal, Mohd-Hafifi, et al.
Publicado: (2012)

Immunological Aspects of Viral Oncolysis
por: Stim, Thomas B.
Publicado: (1967)

Mechanisms of Oncolysis by Paramyxovirus Sendai
por: Matveeva, O. V., et al.
Publicado: (2015)

MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma
por: Zhuang, Zehang, et al.
Publicado: (2020)

Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells in vivo
por: YAN, YULAN, et al.
Publicado: (2014)

Oncolysis by paramyxoviruses: preclinical and clinical studies
por: Matveeva, Olga V, et al.
Publicado: (2015)

Current understanding of reovirus oncolysis mechanisms
por: Phillips, Matthew B, et al.
Publicado: (2018)

Proteolytic Disassembly Is a Critical Determinant for Reovirus Oncolysis
por: Alain, Tommy, et al.
Publicado: (2007)

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2018)

MicroRNA-204 regulates osteogenic induction in dental follicle cells
por: Ito, Ko, et al.
Publicado: (2020)

Mir-204 Regulates LPS-Induced A549 Cell Damage by Targeting FOXK2
por: Li, Shufen, et al.
Publicado: (2021)

Comparative analysis of microRNA expression profiles between A549, A549/DDP and their respective exosomes
por: Qin, Xiaobing, et al.
Publicado: (2017)

MicroRNA-9 functions as a tumor suppressor and enhances radio-sensitivity in radio-resistant A549 cells by targeting neuropilin 1
por: Xiong, Kai, et al.
Publicado: (2018)

Attenuated reovirus displays oncolysis with reduced host toxicity
por: Kim, M, et al.
Publicado: (2011)

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency
por: Matveeva, Olga V, et al.
Publicado: (2015)

Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition
por: Fernandes, Janaina
Publicado: (2016)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Thioredoxin-interacting protein regulates insulin transcription through microRNA-204
por: Xu, Guanlan, et al.
Publicado: (2013)

Retracted: Mir-204 Regulates LPS-Induced A549 Cell Damage by Targeting FOXK2
por: Healthcare Engineering, Journal of
Publicado: (2023)

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2015)

MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor
por: Chen, Yan, et al.
Publicado: (2019)

Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors
por: MacTavish, Heather, et al.
Publicado: (2010)

Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis
por: Pan, Da, et al.
Publicado: (2013)

Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization
por: Sharp, Daniel W., et al.
Publicado: (2016)

NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma
por: Kennedy, Barry E., et al.
Publicado: (2022)

Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma
por: Cerqueira, Otto Luiz Dutra, et al.
Publicado: (2022)

MicroRNA-204 Is Necessary for Aldosterone-Stimulated T-Type Calcium Channel Expression in Cardiomyocytes
por: Koyama, Riko, et al.
Publicado: (2018)

MicroRNA-204 Deficiency in Human Aortic Valves Elevates Valvular Osteogenic Activity
por: Song, Rui, et al.
Publicado: (2019)

microRNA-204-5p Participates in Atherosclerosis Via Targeting MMP-9
por: Wang, Na, et al.
Publicado: (2020)

MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide
por: Wang, Zhiguo, et al.
Publicado: (2019)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1
por: Xiao, Ling, et al.
Publicado: (2016)

MicroRNA-204 may participate in the pathogenesis of hypoxic-ischemic encephalopathy through targeting KLLN
por: Chen, Ronglin, et al.
Publicado: (2019)

MicroRNA-204 Inhibits the Growth and Motility of Colorectal Cancer Cells by Downregulation of CXCL8
por: Shuai, Feng, et al.
Publicado: (2018)

The Demonstration of an Inhibitor of Oncolysis in the Ascitic Fluid from the Ehrlich Ascites Carcinoma
por: Hartveit, F.
Publicado: (1964)

Autophagy inhibition and microRNA-199a-5p upregulation in paclitaxel-resistant A549/T lung cancer cells
por: Zeng, Tianjiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bfn5lfpn6oop4lfa3tirkj55gq